336 related articles for article (PubMed ID: 16945390)
1. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
Stuart EC; Scandlyn MJ; Rosengren RJ
Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
Gupta S; Ahmad N; Nieminen AL; Mukhtar H
Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
[TBL] [Abstract][Full Text] [Related]
4. Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro.
Zhang LC; Yu HN; Sun SL; Yang JG; He GQ; Ruan H; Shen SR
Toxicol In Vitro; 2008 Jun; 22(4):953-60. PubMed ID: 18359184
[TBL] [Abstract][Full Text] [Related]
5. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
6. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
8. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
Khan N; Afaq F; Saleem M; Ahmad N; Mukhtar H
Cancer Res; 2006 Mar; 66(5):2500-5. PubMed ID: 16510563
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies.
Park OJ; Surh YJ
Toxicol Lett; 2004 Apr; 150(1):43-56. PubMed ID: 15068824
[TBL] [Abstract][Full Text] [Related]
10. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
[TBL] [Abstract][Full Text] [Related]
13. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
Sadava D; Whitlock E; Kane SE
Biochem Biophys Res Commun; 2007 Aug; 360(1):233-7. PubMed ID: 17585882
[TBL] [Abstract][Full Text] [Related]
14. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice.
Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ
Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968
[TBL] [Abstract][Full Text] [Related]
15. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
[TBL] [Abstract][Full Text] [Related]
16. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
17. [Multiple actions of EGCG, the main component of green tea].
L'Allemain G
Bull Cancer; 1999 Sep; 86(9):721-4. PubMed ID: 10519963
[TBL] [Abstract][Full Text] [Related]
18. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
19. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
20. Study of the combined effect of X-irradiation and epigallocatechin-gallate (a tea component) on the growth inhibition and induction of apoptosis in human cancer cell lines.
Baatout S; Jacquet P; Derradji H; Ooms D; Michaux A; Mergeay M
Oncol Rep; 2004 Jul; 12(1):159-67. PubMed ID: 15201978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
